Tecnologia usada p/ #vacinas #Covid desenvolveu tratamento #Alzheimer Anticorpo Lecacemab limpa depósitos amiloides, placas que deixam condução lentas, no cérebro foi aprovado @US_FDA 2023. Resultado confirmado no eMERGE Nat Genome Human Research. https:/
@BursatilBiotech @BrianSkorney For those unfamiliar with Paul Aisen, the conflict of interest statement here is telling. $BIIB doing its best to destroy whatever respect it has left. https://t.co/nELJvfZ1on
Des de llavors han estat bastants els escrits, editorials i publicacions a favor i en contra d'aquesta aprovació. https://t.co/lvMR4LOQzt https://t.co/AGqfOheGG9 https://t.co/Me8PWfrqzA
Cynthia Lemere contributed to this aducanumab affirmation, Cummings et al. https://t.co/SLKV8hrqUt